表紙
市場調查報告書

全球微膠囊市場(至2025年):噴霧劑,乳劑,滴劑

Microcapsule Market by Technology (Spray, Emulsion, Dripping), End-use Industry (Pharmaceutical & Healthcare, Food & Beverage, Household & Personal Care, Textile, Agrochemical, Others), Shell Material, Core Material, & Region-Global Forecast to 2025

出版商 MarketsandMarkets 商品編碼 949952
出版日期 內容資訊 英文 233 Pages
訂單完成後即時交付
價格
全球微膠囊市場(至2025年):噴霧劑,乳劑,滴劑 Microcapsule Market by Technology (Spray, Emulsion, Dripping), End-use Industry (Pharmaceutical & Healthcare, Food & Beverage, Household & Personal Care, Textile, Agrochemical, Others), Shell Material, Core Material, & Region-Global Forecast to 2025
出版日期: 2020年06月30日內容資訊: 英文 233 Pages
簡介

在預測期內,全球微膠囊市場預計將以9.8%的複合年增長率增長,從2020年的87億美元增長到2025年的139億美元。該地區的增長是由諸如食品行業,製藥行業和農用化學品的需求增加,積極研發以提高流程效率以及擴大應用等因素驅動的。按外殼材料,三聚氰胺行業預計將在預測期內以最高複合年增長率增長。該部門的增長受到個人護理產品中對不含甲醛的三聚氰胺需求的增長所推動。三聚氰胺外殼材料具有出色的揮發性分子保留能力和可調節的機械性能,使其非常適合作為傳統氨基塑料微膠囊的無甲醛替代品。

該報告調查了全球微膠囊市場,定義和概述了市場,分析了價值鏈,COVID-19和其他市場影響因素,市場規模趨勢和預測,技術和最終用戶行業。□殼材料,核心材料,地區/主要國家/地區,競爭環境,主要公司的概況等各種類別的細分

第1章簡介

第2章調查方法

第3章執行摘要

第4章重要注意事項

第5章市場概述

  • 市場動態
    • 主持人
    • 市場機會
    • 挑戰
  • 波特的五力分析
  • 趨勢
  • 價值鏈分析

第6章監管框架

第7章COVID-19的影響

第8章按技術進行市場分析和預測

  • 噴霧
    • 噴霧乾燥
    • 噴霧冷卻
  • 乳液
    • 原位聚合
    • 凝聚
    • 溶膠凝膠法
  • 滴灌
      旋轉盤/懸浮液分離
    • 離心提取
  • 其他

第9章最終用戶行業的市場分析和預測

  • 藥品和醫療保健
    • 釋放控制
    • 特定藥物的運送
    • 掩味
  • 食物和飲料
    • 益生菌
    • 抗氧化劑
    • 維生素
    • 食用色素
  • 家用產品/個人護理產品
    • 精油
    • 多酚化合物
    • 香水和香水
  • 纖維
    • 熱致變色材料
    • 芬芳完成
    • 阻燃劑
    • 防水
    • 柔軟劑/抗靜電劑
    • 洗滌劑添加劑
    • 香水和香水
  • 農藥
  • 其他

第10章殼材料市場分析和預測

  • 三聚氰胺
  • 非三聚氰胺
    • 聚合物
    • 口香糖/樹脂 碳水化合物
    • 蛋白質
    • 脂質

第11章按核心材料進行的市場分析和預測

  • 製藥
  • 食品添加劑
  • 農業材料
  • 相變材料
  • 其他

第12章按地區和主要國家進行的市場分析和預測

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東/非洲

第13章競爭情況

  • 概述
  • 競爭態勢圖
  • 競爭基準
  • 主要公司排名
  • 競爭場景

第14章公司簡介

  • BASF SE
  • ROYAL FRIESLANDCAMPINA N.V.
  • SYNGENTA CROP PROTECTION AG
  • KONINKLIJKE DSM N.V.
  • GIVAUDAN S.A.
  • SYMRISE AG
  • SENSIENT TECHNOLOGIES CORPORATION
  • LYCORED CORP.
  • KOEHLER INNOVATIVE SOLUTIONS
  • BALCHEM CORPORATION
  • CAPSULA SAS
  • TASTETECH LTD.
  • MICROCAPSULES TECHNOLOGIES (MCT)
  • INSILICO CO. LTD.
  • INTERNATIONAL FLAVORS & FRAGRANCES
  • MATSUMOTO YUSHI SEIYAKU CO., LTD.
  • ENCAPSYS
  • ARCADE BEAUTY
  • REED PACIFIC
  • FIRMENICH SA
  • 其他有力企業
    • RONALD T. DODGE COMPANY
    • MICROTEK LABORATORIES, INC.
    • AVEKA, INC.
    • INNOBIO
    • GAT MICROENCAPSULATION GMBH
    • BRACE GMBH
    • TAGRA BIOTECHNOLOGIES LTD.

第15章 附錄

目錄
Product Code: CH 7692

"The microcapsule market is projected to grow at a CAGR of 9.8% from 2020 to 2025, in terms of value."

The microcapsule market is projected to grow from USD 8.7 billion in 2020 to USD 13.9 billion by 2025, at a CAGR of 9.8% from 2020 to 2025. The major reasons for the growth of the microcapsule market include increasing demand from the food industry, high demand from the pharmaceutical industry, rising demand from the agrochemical sector, increased R&D activities for process efficiency to enhance market penetration, and widespread applications of microcapsules

"The melamine segment is estimated to lead the microcapsule market in terms of value from 2020 to 2025."

By shell material, the melamine segment is projected to grow with the highest CAGR during the forecast period. The growth of the melamine segment is attributed to the increasing demand for formaldehyde-free melamine in personal care products. Additionally, melamine shell materials offer excellent retention capacity for volatile molecules and tunable mechanical properties that make these melamine capsules highly suitable as a formaldehyde-free alternative to conventional aminoplast microcapsules. These factors have resulted in the growth in demand for melamine shell materials in microcapsule market.

"Pharmaceutical & Healthcare Drugs accounted for the largest share of the microcapsule market, by source."

By core material, the pharmaceutical & healthcare drugs segment accounted for the largest share of the microcapsule market in 2019. The increasing demand for the masking of oral drug flavors to drive the growth of the pharmaceutical & healthcare drugs segment. Also, Intensive marketing by key players and increased applications of nutritional elements in functional and fortified foods drive the demand for pharmaceutical & healthcare drugs.

"Pharmaceutical & Healthcare accounted for the largest share of the microcapsule market, by source."

By end-use industry, the pharmaceutical & healthcare segment accounted for the largest share of the microcapsule market in 2019. Factors like controlled release of drugs, timely delivery of functional ingredients, and taste masking properties of microcapsules drives the growth of the microcapsule market in the pharmaceutical & healthcare end-use industry segment.

"Dripping Technologies segment is estimated to lead the microcapsule market in terms of value from 2020 to 2025."

By technology, the dripping technologies segment is projected to grow with the highest CAGR during the forecast period. Dripping technologies include droplet extrusion through spinning disks, jet breakage systems, and coextrusion. These technologies are applied for liquid, solid, hydrophilic, and lipophilic materials. The major advantages of dripping technologies are biocompatibility and low particle size distribution, which is expected to drive the growth for dripping technologies. Also, growing demand for microencapsulated active ingredients in pharmaceutical industry to drive market growth for dripping technologies.

"North America is projected to lead the microcapsule market during the forecast period, in terms of value."

The North American region is projected to lead the microcapsule market from 2020 to 2025 in terms of value. The microcapsule market in North America is majorly driven by the growing demand and consumer awareness about value-added products in various areas, such as nutrition, food, healthcare, and personal care.

Profile break-up of primary participants for the report:

  • By Company Type: Tier 1 - 65%, Tier 2 - 20%, and Tier 3 - 15%
  • By Designation: C-level Executives - 25%, Directors - 30%, and Others - 45%
  • By Region: North America - 30%, Europe - 20%, Asia Pacific - 40%, South America - 3%, Middle East & Africa - 7%,

As a part of qualitative analysis, the research provides a comprehensive review of market drivers, restraints, opportunities, and challenges. It also discusses competitive strategies adopted by varied market players, such as BASF SE (Germany), International Flavors & Fragrances (US), Koninklijke DSM N.V. (Netherlands), Symrise AG (Germany), Givaudan S.A. (Switzerland), Sensient Technologies Corporation (US), Royal FrieslandCampina N.V. (Netherlands), Syngenta Crop Protection AG (Switzerland), Lycored Corp. (Israel), Koehler Innovative Solutions (Germany), Balchem Corporation (US), Capsulæ SAS (France), TasteTech Ltd. (UK), MicroCapsules Technologies (MCT) (France), INSILICO Co. Ltd. (South Korea), Matsumoto Yushi Seiyaku Co., Ltd. (Japan), Encapsys (US), Arcade Beauty (US), Reed Pacific (Australia), Firmenich SA (Switzerland), Ronald T. Dodge Company (US), Microtek Laboratories, Inc. (US), AVEKA, Inc. (US), INNOBIO (China), GAT Microencapsulation GmbH (Austria), BRACE GmbH (Germany), and Tagra Biotechnologies Ltd. (Israel).

Research Coverage:

The report defines, segments, and projects the microcapsule market based on shell material, core material, end-use industry, technology, and region. It provides detailed information regarding the major factors influencing the growth of the market, such as drivers, restraints, opportunities, and industry-specific challenges. It strategically profiles key players and comprehensively analyzes their market shares and core competencies as well as tracks and analyzes competitive developments, such as expansions, acquisitions, new product launches, and partnerships undertaken by them in the market.

Reasons to Buy the Report:

The report is expected to help the market leaders/new entrants in the market by providing them the closest approximations of revenue numbers of the microcapsule market and its segments. This report is also expected to help stakeholders obtain an improved understanding of the competitive landscape of the market, gain insights to improve the position of their businesses, and make suitable go-to-market strategies. It also enables stakeholders to understand the pulse of the market and provide them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MICROCAPSULE MARKET SEGMENTATION
    • 1.3.2 GEOGRAPHIC SCOPE
    • 1.3.3 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 MICROCAPSULE MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primary interviews
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 APPROACH ONE (BASED ON THE GLOBAL MARKET)
    • FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    • 2.2.2 APPROACH TWO (BASED ON CORE MATERIAL, BY REGION)
    • FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 5 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS & LIMITATIONS
    • 2.4.1 ASSUMPTIONS
    • 2.4.2 LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 6 PHARMACEUTICAL & HEALTHCARE END-USE INDUSTRY SEGMENT TO LEAD MICROCAPSULE MARKET DURING FORECAST PERIOD
    • FIGURE 7 SPRAY TECHNOLOGIES SEGMENT ESTIMATED TO DOMINATE MICROCAPSULE MARKET IN 2020
    • FIGURE 8 PHARMACEUTICAL & HEALTHCARE DRUGS SEGMENT TO LEAD MICROCAPSULE MARKET DURING FORECAST PERIOD
    • FIGURE 9 NORTH AMERICA ACCOUNTED FOR LARGEST SHARE OF MICROCAPSULE MARKET IN 2019

4 PREMIUM INSIGHTS

  • 4.1 SIGNIFICANT OPPORTUNITIES IN MICROCAPSULE MARKET
    • FIGURE 10 INCREASE IN DEMAND FROM FOOD AND PHARMACEUTICAL INDUSTRIES TO DRIVE MICROCAPSULE MARKET
  • 4.2 NORTH AMERICA MICROCAPSULE MARKET, BY END-USE INDUSTRY AND COUNTRY
    • FIGURE 11 US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICA MICROCAPSULE MARKET IN 2019
  • 4.3 MICROCAPSULE MARKET, BY REGION
    • FIGURE 12 MICROCAPSULE MARKET IN SOUTH AMERICA PROJECTED TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.4 MICROCAPSULE MARKET, BY END-USE INDUSTRY
    • FIGURE 13 PHARMACEUTICAL & HEALTHCARE SEGMENT ESTIMATED TO LEAD MICROCAPSULE MARKET DURING FORECAST PERIOD
  • 4.5 MICROCAPSULE MARKET, BY TECHNOLOGY
    • FIGURE 14 DRIPPING TECHNOLOGIES SEGMENT PROJECTED TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
  • 4.6 MICROCAPSULE MARKET, BY CORE MATERIAL
    • FIGURE 15 PHARMACEUTICAL & HEALTHCARE DRUGS SEGMENT ESTIMATED TO LEAD MICROCAPSULE MARKET DURING FORECAST PERIOD
  • 4.7 MICROCAPSULE MARKET IN INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
    • FIGURE 16 INDIA PROJECTED TO BE FASTEST-GROWING COUNTRY-LEVEL MARKET FOR MICROCAPSULE FROM 2020 TO 2025

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
    • TABLE 1 MICROENCAPSULATION TECHNIQUES
    • TABLE 2 COMPARATIVE STUDY: ADVANTAGES AND DISADVANTAGES OF MICROENCAPSULATION TECHNIQUES
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 FORCES GOVERNING MICROCAPSULE MARKET
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increase in demand from the food industry
        • 5.2.1.1.1 Growing demand for modified functional food products
    • FIGURE 18 INCREASING HEALTHCARE EXPENDITURE IN MAJOR ECONOMIES, 2015-2019
      • 5.2.1.2 High demand from the pharmaceutical industry
    • TABLE 3 MOST WIDELY USED MICROENCAPSULATED DRUGS IN PHARMACEUTICAL INDUSTRY
        • 5.2.1.2.1 Controlled drug delivery
        • 5.2.1.2.2 Targeted drug delivery
      • 5.2.1.3 Rising demand from the agrochemical sector
        • 5.2.1.3.1 Controlled release technique to enhance the efficiency of agrochemicals
        • 5.2.1.3.2 Controlled release application for convenience in use
        • 5.2.1.3.3 Reduced application cost
        • 5.2.1.3.4 Increasing environmental concerns
      • 5.2.1.4 Increased R&D activities for process efficiency to enhance market penetration
      • 5.2.1.5 Widespread applications of microcapsules
    • TABLE 4 MAJOR END-USE INDUSTRIES FOR MICROENCAPSULATION
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Development of advanced technologies to tap niche markets
        • 5.2.2.1.1 Need for multi-component delivery systems
      • 5.2.2.2 Emerging economies to provide high growth opportunities
        • 5.2.2.2.1 Government support in developing countries
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Stability of microencapsulated ingredients in varying atmospheric conditions
      • 5.2.3.2 Regulatory hindrance
    • TABLE 5 REGULATIONS ON MAXIMUM PERMISSIBLE RESIDUE LEVEL OF FORMALDEHYDE IN TEXTILES (PPM OR PARTS PER MILLION): EUROPE
    • TABLE 6 REGULATIONS ON MAXIMUM PERMISSIBLE RESIDUE LEVEL OF FORMALDEHYDE IN TEXTILES (PPM OR PARTS PER MILLION): ASIA PACIFIC
      • 5.2.3.3 Selection of appropriate technology and shell materials for various applications
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 19 PORTERS FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF SUBSTITUTES
    • 5.3.2 THREAT OF NEW ENTRANTS
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 FUTURE TRENDS
    • TABLE 7 FUTURE TRENDS IN THE APPLICATION OF MICROCAPSULES IN INDUSTRIES
    • 5.4.1 FOOD INDUSTRY
  • 5.5 VALUE CHAIN ANALYSIS
    • 5.5.1 INTRODUCTION
    • 5.5.2 VALUE CHAIN ANALYSIS
    • FIGURE 20 MICROENCAPSULATION: DEVELOPMENT AND PRODUCTION ACCOUNTS FOR MAXIMUM CONTRIBUTION TO CUMULATIVE VALUE

6 REGULATORY FRAMEWORK GOVERNING MICROCAPSULE MARKET

  • 6.1 INTRODUCTION
  • 6.2 CODEX ALIMENTARIUS COMMISSION (CAC)
  • 6.3 JOINT EXPERT COMMITTEE ON FOOD AND AGRICULTURE (JECFA)
    • 6.3.1 FDA
    • 6.3.2 EUROPEAN COMMISSION
  • 6.4 COUNTRY-WISE REGULATORY AUTHORITIES FOR MICROENCAPSULATION IN FOOD
    • 6.4.1 NORTH AMERICA
      • 6.4.1.1 US
      • 6.4.1.2 Canada
    • 6.4.2 EUROPE
    • 6.4.3 ASIA PACIFIC
      • 6.4.3.1 Japan
      • 6.4.3.2 India
      • 6.4.3.3 China
    • 6.4.4 REST OF THE WORLD
      • 6.4.4.1 Brazil
      • 6.4.4.2 Australia & New Zealand

7 COVID-19 IMPACT ON MICROCAPSULE MARKET

  • 7.1 INTRODUCTION
    • 7.1.1 COVID-19 IMPACT ON LIVES AND LIVELIHOOD
      • 7.1.1.1 Loss of life
    • TABLE 8 COUNTRY-WISE ANALYSIS OF COVID-19 CASES
      • 7.1.1.2 Economic outlook by the International Monetary Fund (IMF)
    • TABLE 9 COVID-19 IMPACT: ECONOMIC OUTLOOK, 2020-2021
      • 7.1.1.3 Stimulus package by G-20 countries
    • TABLE 10 RELIEF PACKAGES ANNOUNCED BY G-20 COUNTRIES
    • 7.1.2 IMPACT OF COVID-19 ON MICROCAPSULE MARKET: PHARMACEUTICAL INDUSTRY
      • 7.1.2.1 Introduction
      • 7.1.2.2 impact on value Chain: raw material supply
        • 7.1.2.2.1 A short-term hold on new business strategies
        • 7.1.2.2.2 New business opportunity for small scale companies
    • 7.1.3 IMPACT OF COVID-19 ON MICROCAPSULE MARKET: FOOD& BEVERAGE INDUSTRY
      • 7.1.3.1 Introduction
      • 7.1.3.2 Growing awareness about functional & fortified food products
      • 7.1.3.3 Surging demand for Omega-3 and natural anti-oxidants
      • 7.1.3.4 Ongoing research activities supporting the growth of nutraceutical food products
      • 7.1.3.5 High demand for probiotic supplements
    • 7.1.4 IMPACT OF COVID-19 ON MICROCAPSULE MARKET: TEXTILE INDUSTRY
      • 7.1.4.1 Declining market for fashion clothing
      • 7.1.4.2 Continuously operating medical and military clothing markets
    • 7.1.5 CONCLUSION

8 MICROCAPSULE MARKET, BY TECHNOLOGY

  • 8.1 INTRODUCTION
    • TABLE 11 MICROENCAPSULATION TECHNOLOGIES
    • FIGURE 21 MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
    • TABLE 12 MICROENCAPSULATION TECHNIQUES WITH THEIR RELATIVE PARTICLE SIZE RANGES
    • TABLE 13 MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • 8.2 SPRAY TECHNOLOGIES
    • 8.2.1 SPRAY DRYING
      • 8.2.1.1 Demand for fortified food products to drive demand for spray drying microencapsulation
    • 8.2.2 SPRAY CHILLING
      • 8.2.2.1 Growing demand for microencapsulated food additives to drive market demand
    • TABLE 14 SPRAY TECHNOLOGIES: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 EMULSION TECHNOLOGIES
    • 8.3.1 IN-SITU POLYMERIZATION
      • 8.3.1.1 Advancement of polymerization techniques in microencapsulated drugs, colors, & fragrance applications
    • 8.3.2 COACERVATION
      • 8.3.2.1 Demand for essential oils, flavors, and fragrances to drive demand for coacervation technique
    • 8.3.3 SOL-GEL ENCAPSULATION
      • 8.3.3.1 Adoption of sol-gel encapsulation technique in microencapsulation of construction materials to drive market demand
    • TABLE 15 EMULSION TECHNOLOGIES: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 8.4 DRIPPING TECHNOLOGIES
    • 8.4.1 SPINNING DISK/ROTATIONAL SUSPENSION SEPARATION
      • 8.4.1.1 Atomization, high production, and scalability to increase demand for spinning disk/rotating suspension separation technique
    • 8.4.2 CENTRIFUGAL EXTRUSION
      • 8.4.2.1 Growing demand for microencapsulated active ingredients in pharmaceutical industry
    • TABLE 16 DRIPPING TECHNOLOGIES: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 8.5 OTHERS
    • 8.5.1 FLAVOR MASKING AND NANOENCAPSULATION ARE TRENDING
    • TABLE 17 OTHERS TECHNOLOGIES: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)

9 MICROCAPSULE MARKET, BY END-USE INDUSTRY

  • 9.1 INTRODUCTION
    • TABLE 18 MICROENCAPSULATION METHODS AND APPLICATIONS
    • FIGURE 22 MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2020 VS. 2025 (USD MILLION)
    • TABLE 19 MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
  • 9.2 PHARMACEUTICAL & HEALTHCARE
    • 9.2.1 CONTROLLED RELEASE
    • 9.2.2 SPECIFIC DRUG DELIVERY
    • TABLE 20 MICROENCAPSULATED DRUGS AND BIOPHARMACEUTICS
    • 9.2.3 TASTE MASKING
    • TABLE 21 PHARMACEUTICAL & HEALTHCARE: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 9.3 FOOD & BEVERAGE
    • TABLE 22 METHODS FOR MICROENCAPSULATING FOOD INGREDIENTS
    • 9.3.1 PROBIOTICS
    • TABLE 23 APPLICATIONS OF MICROENCAPSULATION IN PROBIOTIC BACTERIA
    • 9.3.2 ANTIOXIDANTS
    • 9.3.3 VITAMINS
    • 9.3.4 FOOD COLORANTS
    • 9.3.5 FOOD FLAVORS
    • TABLE 24 FOOD & BEVERAGE: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 9.4 HOUSEHOLD & PERSONAL CARE
    • 9.4.1 ESSENTIAL OILS
    • 9.4.2 POLYPHENOLIC COMPOUNDS
    • 9.4.3 FRAGRANCES & PERFUMES
    • TABLE 25 HOUSEHOLD & PERSONAL CARE: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 9.5 TEXTILE
    • 9.5.1 THERMOCHROMIC MATERIALS
    • 9.5.2 FRAGRANCE FINISHING
    • 9.5.3 FIRE RETARDANTS
    • 9.5.4 WATERPROOFING
    • 9.5.5 SOFTENERS & ANTISTATIC
    • 9.5.6 DETERGENT ADDITIVES
    • 9.5.7 FRAGRANCES & PERFUMES
    • TABLE 26 TEXTILE: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 9.6 AGROCHEMICAL
    • TABLE 27 AGROCHEMICAL: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 9.7 OTHERS
    • TABLE 28 APPLICATIONS OF MICROENCAPSULATION IN CONSTRUCTION MATERIALS
    • TABLE 29 OTHERS: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)

10 MICROCAPSULE MARKET, BY SHELL MATERIAL

  • 10.1 INTRODUCTION
    • TABLE 30 SHELL MATERIALS USED IN MICROCAPSULES
    • FIGURE 23 MICROCAPSULE MARKET SIZE, BY SHELL MATERIAL, 2020 VS. 2025 (USD MILLION)
    • TABLE 31 MICROCAPSULE MARKET SIZE, BY SHELL MATERIAL, 2018-2025 (USD MILLION)
  • 10.2 MELAMINE
    • TABLE 32 MELAMINE: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 10.3 NON-MELAMINE
    • FIGURE 24 MICROCAPSULE MARKET SIZE, BY NON-MELAMINE SHELL MATERIAL, 2020 VS. 2025 (USD MILLION)
    • TABLE 33 NON-MELAMINE: MICROCAPSULE MARKET SIZE, BY NON-MELAMINE SHELL MATERIAL, 2018-2025 (USD MILLION)
    • TABLE 34 NON-MELAMINE: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
    • 10.3.1 POLYMERS
    • TABLE 35 BIODEGRADABLE AND NON-BIODEGRADABLE POLYMER SHELL MATERIALS IN MICROCAPSULES
      • 10.3.1.1 Melamine Formaldehyde
    • TABLE 36 MELAMINE FORMALDEHYDE: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
      • 10.3.1.2 Other polymers
    • TABLE 37 OTHER POLYMERS: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
    • 10.3.2 GUMS & RESINS
    • TABLE 38 GUMS & RESINS: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
    • 10.3.3 CARBOHYDRATES
      • 10.3.3.1 Cellulose derivatives are the commonly used shell materials for food, pharma, and cosmetic applications
      • 10.3.3.2 Organic components are preferred in major applications
    • TABLE 39 CARBOHYDRATES: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
    • 10.3.4 PROTEINS
      • 10.3.4.1 Gelatin-based microcapsules to drive the protein shell material market
    • TABLE 40 PROTEINS: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
    • 10.3.5 LIPIDS
      • 10.3.5.1 Increasing applications in emulsion technology drive the market for lipid shell material
    • TABLE 41 LIPIDS: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)

11 MICROCAPSULE MARKET, BY CORE MATERIAL

  • 11.1 INTRODUCTION
    • TABLE 42 MICROCAPSULE PROCESS AND APPLICABLE CORE MATERIAL
    • FIGURE 25 MICROCAPSULE MARKET SIZE, BY CORE MATERIAL, 2020 VS. 2025 (USD MILLION)
    • TABLE 43 MICROCAPSULE MARKET SIZE, BY CORE MATERIAL, 2018-2025 (USD MILLION)
  • 11.2 PHARMACEUTICAL & HEALTHCARE DRUGS
    • 11.2.1 GROWING DEMAND FOR FLAVOR AND COLOR MASKING IN ORAL DRUGS TO DRIVE PHARMACEUTICAL & HEALTHCARE DRUGS' CORE MATERIAL MARKET
    • TABLE 44 POTENTIAL BENEFITS OF MICROCAPSULES IN NUTRACEUTICALS SECTOR
    • TABLE 45 PHARMACEUTICAL & HEALTHCARE DRUGS: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 11.3 FOOD ADDITIVES
    • 11.3.1 ACIDULANTS, FLAVORING & COLORING AGENTS, AND VITAMINS & MINERALS ARE LARGELY USED AS CORE MATERIAL FOR FOOD FORTIFICATION
    • TABLE 46 FOOD ADDITIVES: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 11.4 FRAGRANCES
    • 11.4.1 EUROPE TO DOMINATE THE FRAGRANCES SEGMENT ON A GLOBAL LEVEL
    • TABLE 47 FRAGRANCES: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 11.5 AGRICULTURAL INPUTS
    • 11.5.1 AGRICULTURAL INPUTS AS CORE MATERIALS MITIGATE ENVIRONMENTAL AND HEALTH RISKS
    • TABLE 48 AGRICULTURAL INPUTS: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 11.6 PHASE CHANGE MATERIALS
    • 11.6.1 TEXTILE AND CONSTRUCTION TO DRIVE PCM CORE MATERIAL MARKET
    • TABLE 49 PHASE CHANGE MATERIALS: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 11.7 OTHERS
    • 11.7.1 HIGH DEMAND FOR MICROCAPSULES IN INKS AND CARBONLESS PAPER
    • TABLE 50 OTHERS: MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)

12 MICROCAPSULE MARKET, BY REGION

  • 12.1 INTRODUCTION
    • FIGURE 26 US ACCOUNTED FOR LARGEST SHARE OF MICROCAPSULE MARKET IN 2019
    • TABLE 51 MICROCAPSULE MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
  • 12.2 NORTH AMERICA
    • TABLE 52 NORTH AMERICA: FOOD ENCAPSULATION MARKET SIZE, BY COUNTRY, 2018-2025 (USD MILLION)
    • FIGURE 27 NORTH AMERICA MICROCAPSULE MARKET SNAPSHOT
    • TABLE 53 NORTH AMERICA: MICROCAPSULE MARKET SIZE, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 54 NORTH AMERICA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 55 NORTH AMERICA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 56 NORTH AMERICA: MICROCAPSULE MARKET SIZE, BY CORE MATERIAL, 2018-2025 (USD MILLION)
    • TABLE 57 NORTH AMERICA: MICROCAPSULE MARKET SIZE, BY SHELL MATERIAL, 2018-2025 (USD MILLION)
    • TABLE 58 NORTH AMERICA: MICROCAPSULE MARKET SIZE, BY NON-MELAMINE SHELL MATERIAL, 2018-2025 (USD MILLION)
    • 12.2.1 US
      • 12.2.1.1 Innovations and strategic collaborations to upsurge microcapsule market
    • TABLE 59 US: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 60 US: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.2.2 CANADA
      • 12.2.2.1 HIGH DEMAND FOR MICROCAPSULES IN FOOD & BEVERAGE INDUSTRY IN CANADA DRIVING THE MARKET GROWTH
    • TABLE 61 CANADA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 62 CANADA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.2.3 MEXICO
      • 12.2.3.1 Food and agrochemical applications to grow at high rates in next five years
    • TABLE 63 MEXICO: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 64 MEXICO: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • 12.3 EUROPE
    • FIGURE 28 EUROPE MICROCAPSULE MARKET SNAPSHOT
    • TABLE 65 EUROPE: MICROCAPSULE MARKET SIZE, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 66 EUROPE: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 67 EUROPE: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 68 EUROPE: MICROCAPSULE MARKET SIZE, BY CORE MATERIAL, 2018-2025 (USD MILLION)
    • TABLE 69 EUROPE: MICROCAPSULE MARKET SIZE, BY SHELL MATERIAL, 2018-2025 (USD MILLION)
    • TABLE 70 EUROPE: MICROCAPSULE MARKET SIZE, BY NON-MELAMINE SHELL MATERIAL, 2018-2025 (USD MILLION)
    • 12.3.1 GERMANY
    • TABLE 71 GERMANY: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 72 GERMANY: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.3.2 UK
      • 12.3.2.1 Growth in application of PCMs and fragrances in UK textile industry
    • TABLE 73 UK: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 74 UK: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.3.3 FRANCE
      • 12.3.3.1 Nutraceutical to be fastest-growing market for microcapsules in France
    • TABLE 75 FRANCE: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 76 FRANCE: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.3.4 ITALY
      • 12.3.4.1 Increasing production of pharmaceuticals to drive market growth
    • TABLE 77 ITALY: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 78 ITALY: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.3.5 SPAIN
    • TABLE 79 SPAIN: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 80 SPAIN: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.3.6 REST OF EUROPE
    • TABLE 81 REST OF EUROPE: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 82 REST OF EUROPE: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • 12.4 ASIA PACIFIC
    • FIGURE 29 ASIA PACIFIC MICROCAPSULE MARKET SNAPSHOT
    • TABLE 83 ASIA PACIFIC: MICROCAPSULE MARKET SIZE, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 85 ASIA PACIFIC: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 86 ASIA PACIFIC: MICROCAPSULE MARKET SIZE, BY CORE MATERIAL, 2018-2025 (USD MILLION)
    • TABLE 87 ASIA PACIFIC: MICROCAPSULE MARKET SIZE, BY SHELL MATERIAL, 2018-2025 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: MICROCAPSULE MARKET SIZE, BY NON-MELAMINE SHELL MATERIAL, 2018-2025 (USD MILLION)
    • 12.4.1 CHINA
      • 12.4.1.1 Microcapsule market in China majorly driven by pharmaceutical & healthcare end-use industry
    • TABLE 89 CHINA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 90 CHINA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.4.2 JAPAN
      • 12.4.2.1 Growing food and household & personal care industries driving the microcapsule market growth in Japan
    • TABLE 91 JAPAN: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 92 JAPAN: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.4.3 SOUTH KOREA
      • 12.4.3.1 Growing pharmaceutical industry driving the microcapsule market
    • TABLE 93 SOUTH KOREA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 94 SOUTH KOREA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.4.4 INDIA
      • 12.4.4.1 Growing pharmaceutical, food, and personal care industries to drive the market growth
    • TABLE 95 INDIA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 96 INDIA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.4.5 INDONESIA
      • 12.4.5.1 Spray technologies segment dominated the microcapsule market in Indonesia
    • TABLE 97 INDONESIA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 98 INDONESIA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.4.6 MALAYSIA
      • 12.4.6.1 Growing pharmaceutical industry in the country
    • TABLE 99 MALAYSIA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 100 MALAYSIA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.4.7 REST OF ASIA PACIFIC
    • TABLE 101 REST OF ASIA PACIFIC: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 102 REST OF ASIA PACIFIC: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • 12.5 SOUTH AMERICA
    • TABLE 103 SOUTH AMERICA: MICROCAPSULE MARKET SIZE, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 104 SOUTH AMERICA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 105 SOUTH AMERICA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 106 SOUTH AMERICA: MICROCAPSULE MARKET SIZE, BY CORE MATERIAL, 2018-2025 (USD MILLION)
    • TABLE 107 SOUTH AMERICA: MICROCAPSULE MARKET SIZE, BY SHELL MATERIAL, 2018-2025 (USD MILLION)
    • TABLE 108 SOUTH AMERICA: MICROCAPSULE MARKET SIZE, BY NON-MELAMINE SHELL MATERIAL, 2018-2025 (USD MILLION)
    • 12.5.1 BRAZIL
      • 12.5.1.1 Expansions by microcapsule companies in Brazil present market growth opportunities
    • TABLE 109 BRAZIL: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 110 BRAZIL: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.5.2 ARGENTINA
      • 12.5.2.1 Growing functional food industry to drive the microcapsule market
    • TABLE 111 ARGENTINA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 112 ARGENTINA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.5.3 REST OF SOUTH AMERICA
    • TABLE 113 REST OF SOUTH AMERICA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 114 REST OF SOUTH AMERICA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • 12.6 MIDDLE EAST & AFRICA
    • TABLE 115 MIDDLE EAST & AFRICA: MICROCAPSULE MARKET SIZE, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 116 MIDDLE EAST & AFRICA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 117 MIDDLE EAST & AFRICA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 118 MIDDLE EAST & AFRICA: MICROCAPSULE MARKET SIZE, BY CORE MATERIAL, 2018-2025 (USD MILLION)
    • TABLE 119 MIDDLE EAST & AFRICA: MICROCAPSULE MARKET SIZE, BY SHELL MATERIAL, 2018-2025 (USD MILLION)
    • TABLE 120 MIDDLE EAST & AFRICA: MICROCAPSULE MARKET SIZE, BY NON-MELAMINE SHELL MATERIAL, 2018-2025 (USD MILLION)
    • 12.6.1 SAUDI ARABIA
      • 12.6.1.1 Growing pharmaceutical industry to drive the microcapsule market in Saudi Arabia
    • TABLE 121 SAUDI ARABIA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 122 SAUDI ARABIA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.6.2 SOUTH AFRICA
      • 12.6.2.1 Presence of major pharmaceutical manufacturers to drive microcapsule demand in the country
    • TABLE 123 SOUTH AFRICA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 124 SOUTH AFRICA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 12.6.3 REST OF MIDDLE EAST & AFRICA
    • TABLE 125 REST OF MIDDLE EAST & AFRICA: MICROCAPSULE MARKET SIZE, BY END-USE INDUSTRY, 2018-2025 (USD MILLION)
    • TABLE 126 REST OF MIDDLE EAST & AFRICA: MICROCAPSULE MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD MILLION)

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
    • FIGURE 30 COMPANIES ADOPTED BOTH ORGANIC AND INORGANIC GROWTH STRATEGIES BETWEEN JANUARY 2017 AND MAY 2020
  • 13.2 COMPETITIVE LANDSCAPE MAPPING, 2019
    • 13.2.1 VISIONARY LEADERS
    • 13.2.2 INNOVATORS
    • 13.2.3 DYNAMIC DIFFERENTIATORS
    • 13.2.4 EMERGING COMPANIES
    • FIGURE 31 MICROCAPSULE MARKET: (GLOBAL) COMPETITIVE LANDSCAPE MAPPING, 2019
  • 13.3 COMPETITIVE BENCHMARKING
    • 13.3.1 STRENGTH OF PRODUCT PORTFOLIO
    • 13.3.2 BUSINESS STRATEGY EXCELLENCE
  • 13.4 MARKET RANKING OF KEY PLAYERS
  • 13.5 COMPETITIVE SCENARIO
    • 13.5.1 EXPANSIONS
    • TABLE 127 EXPANSIONS, JANUARY 2017- MAY 2020
    • 13.5.2 ACQUISITIONS
    • TABLE 128 ACQUISITIONS, JANUARY 2017- MAY 2020
    • 13.5.3 NEW PRODUCT LAUNCHES
    • TABLE 129 NEW PRODUCT LAUNCHES, JANUARY 2017- MAY 2020
    • 13.5.4 PARTNERSHIPS
    • TABLE 130 PARTNERSHIPS, JANUARY 2017- MAY 2020
    • 13.5.5 INVESTMENTS
    • TABLE 131 INVESTMENTS, JANUARY 2017- MAY 2020
    • 13.5.6 JOINT VENTURES
    • TABLE 132 JOINT VENTURES, JANUARY 2017- MAY 2020
    • 13.5.7 MERGERS
    • TABLE 133 MERGERS, JANUARY 2017- MAY 2020
    • 13.5.8 COLLABORATIONS
    • TABLE 134 COLLABORATIONS, JANUARY 2017- MAY 2020
    • 13.5.9 AGREEMENTS
    • TABLE 135 AGREEMENTS, JANUARY 2017- MAY 2020
    • 13.5.10 DIVESTMENTS
    • TABLE 136 DIVESTMENTS, JANUARY 2017- MAY 2020

14 COMPANY PROFILES

(Business overview, Products offered, Recent Developments, SWOT Analysis, MNM View, Impacts of COVID-19)**

  • 14.1 BASF SE
    • FIGURE 32 BASF SE: COMPANY SNAPSHOT
  • 14.2 ROYAL FRIESLANDCAMPINA N.V.
    • FIGURE 33 ROYAL FRIESLANDCAMPINA N.V.: COMPANY SNAPSHOT
  • 14.3 SYNGENTA CROP PROTECTION AG
    • FIGURE 34 SYNGENTA CROP PROTECTION AG: COMPANY SNAPSHOT
  • 14.4 KONINKLIJKE DSM N.V.
    • FIGURE 35 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
  • 14.5 GIVAUDAN S.A.
    • FIGURE 36 GIVAUDAN S.A.: COMPANY SNAPSHOT
  • 14.6 SYMRISE AG
    • FIGURE 37 SYMRISE AG: COMPANY SNAPSHOT
  • 14.7 SENSIENT TECHNOLOGIES CORPORATION
    • FIGURE 38 SENSIENT TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT
  • 14.8 LYCORED CORP.
  • 14.9 KOEHLER INNOVATIVE SOLUTIONS
  • 14.10 BALCHEM CORPORATION
    • FIGURE 39 BALCHEM CORPORATION: COMPANY SNAPSHOT
  • 14.11 CAPSULÆ SAS
  • 14.12 TASTETECH LTD.
  • 14.13 MICROCAPSULES TECHNOLOGIES (MCT)
  • 14.14 INSILICO CO. LTD.
  • 14.15 INTERNATIONAL FLAVORS & FRAGRANCES
    • FIGURE 40 INTERNATIONAL FLAVORS & FRAGRANCES: COMPANY SNAPSHOT
  • 14.16 MATSUMOTO YUSHI SEIYAKU CO., LTD.
    • FIGURE 41 MATSUMOTO YUSHI SEIYAKU CO., LTD.: COMPANY SNAPSHOT
  • 14.17 ENCAPSYS
  • 14.18 ARCADE BEAUTY
  • 14.19 REED PACIFIC
  • 14.20 FIRMENICH SA
  • 14.21 OTHER COMPANIES
    • 14.21.1 RONALD T. DODGE COMPANY
    • 14.21.2 MICROTEK LABORATORIES, INC.
    • 14.21.3 AVEKA, INC.
    • 14.21.4 INNOBIO
    • 14.21.5 GAT MICROENCAPSULATION GMBH
    • 14.21.6 BRACE GMBH
    • 14.21.7 TAGRA BIOTECHNOLOGIES LTD.

*Details on Business overview, Products offered, Recent Developments, SWOT Analysis, MNM View, Impacts of COVID-19 might not be captured in case of unlisted companies.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 AVAILABLE CUSTOMIZATIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS